Want to see AU:CYC full AI Analyst Report?
Cyclopharm Limited (CYC) Income Statement
Cyclopharm Limited Income Statement
Last quarter (Q2 2026), Cyclopharm Limited's total revenue was $17.52M, an increase of 42.74% from the same quarter last year. In Q2, Cyclopharm Limited's net income was $-8.79M. See Cyclopharm Limited’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 32.33M | $ 27.57M | $ 26.34M | $ 23.22M | $ 17.70M | |
| $ -1.46M | $ 17.93M | $ 16.08M | $ 5.94M | $ 3.20M | |
| $ 16.72M | $ 32.28M | $ 13.72M | $ 13.22M | $ 9.64M | |
| Depreciation and Amortization | $ 1.77M | $ 1.48M | $ 938.83K | $ 931.48K | $ 758.73K |
| $ -16.41M | $ -13.05M | $ -3.84M | $ -6.47M | $ -5.79M | |
| $ -18.18M | $ -14.35M | $ -5.26M | $ -7.28M | $ -6.43M | |
| $ 325.68K | $ 1.45M | $ 5.84M | $ -385.77K | $ -203.81K | |
| $ -17.86M | $ -13.07M | $ -4.19M | $ -7.67M | $ -6.64M | |
| $ -17.22M | $ -13.20M | $ -4.70M | $ -6.61M | $ -5.04M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.16 | $ -0.13 | $ -0.05 | $ -0.07 | $ -0.06 |
| Diluted EPS | $ -0.16 | $ -0.13 | $ -0.05 | $ -0.07 | $ -0.06 |
| Weighted Average Shares Outstanding | 110.13M | 102.87M | 92.66M | 92.18M | 89.57M |
| Weighted Average Shares Outstanding (Diluted) | 110.13M | 102.90M | 92.66M | 92.18M | 89.57M |
Currency in AUD